Positron emission tomography and cancer

Daniel N. Chatzifotiadis, Julia W. Buchanan, Richard L. Wahl

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Positron emission tomography, PET, is a potent imaging tool in the management of a diverse array of cancers. This chapter briefly discusses the rationale for PET imaging and describes how it differs from more typical anatomic imaging, reviews the principles of metabolic targeting with the radiolabeled glucose analogue 18F-fluoro-2-deoxy-d-glucose (FDG), and then describes the clinical results of PET imaging in several types of common cancers. Although there are detailed descriptions of tumor imaging with other modalities in several areas of this textbook, the discussion here focuses on the role of PET.

Original languageEnglish (US)
Title of host publicationOncology
Subtitle of host publicationAn Evidence-Based Approach
PublisherSpringer New York
Pages449-483
Number of pages35
ISBN (Print)0387242910, 9780387242910
DOIs
StatePublished - 2006

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Positron emission tomography and cancer'. Together they form a unique fingerprint.

Cite this